NASDAQ$SONN

Sonnet Biotherapeutics Holdings Inc · Q4 2025 earnings

Q4 2025 earnings · · After market close

Headline financials

Total Revenue

$0.00

No prior period
EPS (adj)

-$0.79

No prior period

Revenue & EPS history

Sonnet Biotherapeutics Holdings Inc · Revenue · Quarterly

$0

Q4 2025

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro